Anthony D Sung, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Campus mail Box 3961 Med Ctr, Durham, NC 27710
Phone (919) 668-1000
Email address anthony.sung@duke.edu

I am dedicated to the treatment of hematologic malignancies through cellular therapies such as hematopoietic stem cell transplantation (HCT). My research focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials. Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections. In addition to advancing new pharmacological and cellular immunotherapies in support of these goals, we also are developing mobile health technologies (mHealth) to monitor patients at home, both as part of our innovative home transplant program as well as to improve follow up care of all our patients when they return home after transplant.

In Their Words

Education and Training

  • Fellowship, Hematology Oncology, Duke University School of Medicine, 2011 - 2014
  • Residency, Osler Medical Housestaff Training Program, Johns Hopkins University School of Medicine, 2008 - 2011
  • M.D., Harvard University , 2008

Publications

Detweiler, CJ, Sung, AD, Saullo, JL, Prasad, VK, and Cardona, DM. "Brincidofovir (CMX001) Toxicity: Another Potential Mimicker of Gastrointestinal Graft Versus Host Disease." February 2016.

Scholars@Duke

Green, MMB, Horwitz, ME, Kang, Y, Chao, NJ, Long, GD, Rizzieri, D, Gasparetto, C, Sung, AD, Sarantopoulos, S, Li, Z, Corbet, K, Riggan-Stuelke, E, Sullivan, K, Wilson, B, Chhabra, S, Costa, LV, Mims, A, and Stuart, R. "Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial.": Elsevier BV, February 2015.

Full Text

Sung, AD, Yen, R, Deoliveira, D, Jiao, Y, Piryani, S, Bernanke, A, Hall, S, Klemp, K, Yun, S, Arepally, G, Hoffman, MR, Ortel, TL, Chao, NJ, and Chen, BJ. "Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding.": Elsevier BV, February 2015.

Full Text

Detweiler, C, Shealy, M, Sung, A, Wild, D, Poleski, M, Balmadrid, B, Cirrincione, C, Li, Z, Sullivan, K, and Cardona, D. "Utilization of the NIH Consensus Guidelines Improves the Diagnostic Accuracy of Gastrointestinal Graft Versus Host Disease: A Five-Year Retrospective Study." February 2015.

Scholars@Duke

Sung, AD, Cardona, D, Rowe, K, Mehdikhani, H, Detweiler, C, Shealy, M, Wild, D, Poleski, M, Cirrincione, C, Li, Z, Chao, NJ, and Sullivan, K. "Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation." February 2015.

Full Text

Detweiler, C, Shealy, M, Sung, A, Wild, D, Poleski, M, Balmadrid, B, Cirrincione, C, Li, Z, Sullivan, K, and Cardona, D. "Utilization of the NIH Consensus Guidelines Improves the Diagnostic Accuracy of Gastrointestinal Graft Versus Host Disease: A Five-Year Retrospective Study." MODERN PATHOLOGY 28 (February 2015): 157A-157A.

Scholars@Duke

Tricot, GJ, and Chao, NJ. "Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone." Bone Marrow Transplantation 48, no. 11 (November 1, 2013): 1444-1449.

Full Text

Sung, AD, and Chao, NJ. "Acute graft-versus-host disease: Are we close to bringing the bench to the bedside?." Best Practice & Research Clinical Haematology 26, no. 3 (September 2013): 285-292.

Full Text

Sung, AD, and Chao, NJ. "Acute graft-versus-host disease: are we close to bringing the bench to the bedside?." Best practice & research. Clinical haematology 26, no. 3 (September 2013): 285-292. (Review)

PMID
24309532
Full Text

Rein, LA, Sung, AD, and Rizzieri, DA. "New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation." Int J Hematol Oncol 2, no. 1 (February 2013).

PMID
24303095
Full Text

Pages